drugset / Trial / NCT02529631
RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This trial compares two treatment methods: 1. Orlistat 60 mg to be taken three times daily one capsule; indicated for weight loss in overweight adults. Important is also that it is taken along with a reduced-calorie and low-fat diet. 2. Polyglucosamine tablets to be taken two times daily two tablets, taken with the two main meals with the highest fat content, indicated for weight maintenance and weight loss.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-06
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Orlistat | Small molecule | 60 mg | Oral |